Catalyst Wire Dossier Catalyst Wire Dossier

0.1% tacrolimus nasal ointment

tacrolimus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0.1% tacrolimus nasal ointment, covering 2020-07-01 to 2020-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT) [Phase 2]

See pricing